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Abstract
A wave of structural reorganization involving centrosomes, microtubules, Golgi complex and ER exit sites takes place early
during skeletal muscle differentiation and completely remodels the secretory pathway. The mechanism of these changes
and their functional implications are still poorly understood, in large part because all changes occur seemingly
simultaneously. In an effort to uncouple the reorganizations, we have used taxol, nocodazole, and the specific GSK3-b
inhibitor DW12, to disrupt the dynamic microtubule network of differentiating cultures of the mouse skeletal muscle cell
line C2. Despite strong effects on microtubules, cell shape and cell fusion, none of the treatments prevented early
differentiation. Redistribution of centrosomal proteins, conditional on differentiation, was in fact increased by taxol and
nocodazole and normal in DW12. Redistributions of Golgi complex and ER exit sites were incomplete but remained tightly
linked under all circumstances, and conditional on centrosomal reorganization. We were therefore able to uncouple
microtubule reorganization from the other events and to determine that centrosomal proteins lead the reorganization
hierarchy. In addition, we have gained new insight into structural and functional aspects of the reorganization of
microtubule nucleation during myogenesis.
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Introduction
The Golgi complex is traditionally thought of as a single
organelle per cell, and represented as a stack of flattened cisternae
next to the nucleus. However, alternative organizations are found
in skeletal [1,2,3] and cardiac [4] muscle, in osteoclasts [5,6], plant
cells [7], yeasts [8], polarized endothelial cells [9] and Drosophila
embryos [10,11]. The Golgi complex organization is also altered
during mitosis [12,13,14], in apoptotic cells [15], in diseases such
as Amyotrophic Lateral Sclerosis [16,17], and in animal models of
diseases such as Duchenne Muscular Dystrophy [18,19,20] and
Pompe Disease [21,22,23]. Understanding how the Golgi complex
transitions between different morphologies should help us assess
the consequences of these modifications.
Skeletal muscle cell cultures are particularly informative since
their Golgi complex transitions from a classic to an alternative
fragmented organization during differentiation. This reorganiza-
tion coincides with changes of the microtubule-organizing center
(MTOC), from a classic centrosome to a combination of
perinuclear belt and centrosomal remnants, and with remodeling
of the microtubule network [1,2,24]. The reorganization of the
Golgi complex also coincides with that of the ER exit sites (ERES)
[1,2,24,25]. The muscle Golgi complex continues to be remodeled
during in vivo myogenesis to form a fiber type-dependent network
of hundreds of small stacks of cisternae, closely associated with
ERES and positioned throughout the fibers [3,26]. These small
Golgi complex elements are associated with a three-dimensional
microtubule lattice [26,27].
Reciprocal relations between the MTOC, microtubules, Golgi
and ERES make the matter more complicated: centrosomes
nucleate microtubules but, conversely, microtubules are involved
in keeping the essential centrosomal proteins pericentrin and c-
tubulin in the centrosome [28,29]. Similarly, microtubules are
necessary for the integrity of the Golgi complex [30], which is
positioned near the centrosome by minus-end directed microtu-
bule motors [31]. However, it is now accepted that the Golgi
complex itself is involved in microtubule nucleation [32,33].
Finally, ERES themselves are positioned along microtubules
through interaction of their COPII coat proteins with dynactin
[34]. Golgi complex elements in differentiated muscle cells can
thus interact with microtubules directly, or indirectly through the
ERES. In light of all these potential interdependencies, the
hierarchy of the microtubule-Golgi complex changes during
muscle differentiation is far from clear.
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changes during myogenesis and during microtubule depolymer-
ization [24,25]: in both cases, the Golgi complex becomes
fragmented, and the resulting elements are positioned at ERES.
However, Golgi fragments produced by microtubule depolymer-
ization do not form a perinuclear belt, but are dispersed through
the cytoplasm [35]. These results suggested that microtubules
might be dispensable for some but not all steps of Golgi complex
reorganization during myogenesis. To test this notion and to
clarify the interdependence of the several reorganizations (MTOC,
microtubules, Golgi complex, ERES), we decided to uncouple
them by using microtubule-altering drugs.
The results presented here show that altering or removing
microtubules does not prevent myogenic reorganizations. Cen-
trosomal proteins provide the platform for the positioning of the
Golgi complex and ERES at the nuclear envelope and emerge as
the key players. We also present evidence that the reorganizations
proceed by progressive modification of existing structures rather
than by demolition and de novo rebuilding.
Finally, we used EB3-GFP to compare microtubule nucleation
in myoblasts and myotubes, at steady-state and after microtubule
depolymerization. These experiments show that nucleation occurs
constantly from the nuclear membrane of myotubes. They also
reveal differences between centrosome and nuclear membrane as
to MTOC organization.
Results
Centrosome, Golgi complex and ERES reorganizations
resist microtubule alterations
In order to assess the participation of microtubules in the
reorganization of MTOC, Golgi complex and ERES during
muscle development, we challenged cultures of the mouse skeletal
muscle cell line C2 [36] to differentiate in the presence of
microtubule-altering drugs. Besides taxol and nocodazole, whose
cell-wide microtubule stabilization and destabilization, respective-
ly, are well known, we also used a specific inhibitor of GSK3-b,
DW12 [37]. Inhibition of GSK3-b affects cell migration in the
wound model by preventing the preferential stabilization of
microtubules in the direction of cell migration [38,39,40]. We
have found that DW12 (like lithium chloride, a much less specific
inhibitor of GSK3-b) stabilizes microtubules preferentially around
the nuclei.
Our aim was to disturb the microtubule network before
differentiation starts in the unsynchronized C2 cultures, while
keeping cells differentiation-competent. Therefore, the drugs were
added 4 hours after plating the cells in growth media (GM). For
each drug, we tested a range of concentrations. We found that
50 ng/ml of nocodazole sufficed to stop cell growth (Figure S1A),
but we used 200 ng/ml, the minimum concentration needed to
remove all large microtubules in 48 hours. A similar test for taxol
and DW12 concentrations led us to choose 50 nM and 100 nM
respectively. After 48 hours in GM in the presence of the drugs,
the desired effects on microtubules were indeed achieved (Figure
S1B). Myogenin, the marker used to assess differentiation, was
expressed in fewer than 15% of the cells (Figure S1C).
Differentiation was initiated by switching the cultures to fusion
medium (FM), and the effects of the treatments were assessed
24 hours later. By that time, control cultures’ expression of
myogenin had increased and small myotubes were present,
indicating that differentiation was well under way.
Figure S2 shows the state of the microtubules at the end of the
treatments. Glu-tubulin, an indicator of microtubule stabilization,
was present with different patterns in taxol and DW12-treated cells
but also in very short microtubules left in nocodazole-treated cells.
We did not consider the inhibition of fusion by nocodazole and
taxol (Figure S2) a hindrance, since the events we are monitoring
precede fusion [24,41]. All quantitations were done on myocytes
(mononucleated, differentiated cells).
We assessed the treatment effects by double-staining for
myogenin versus pericentrin, GM130, or Sec31, to probe for
reorganization of centrosome, Golgi complex, and ERES
respectively and distinguish differentiated from undifferentiated
cells. Results for pericentrin are shown in Figure 1. All cultures,
regardless of treatment, showed increased myogenin expression.
Furthermore, a large fraction of the myogenin-positive cells
showed the perinuclear pericentrin staining typical of normal
differentiation, even when cell and nuclear shape were abnormal.
In contrast, none of the myogenin-negative cells showed
reorganized pericentrin. Similarly, the Golgi complex and ERES
were redistributed to the nuclear envelope of many of the
myogenin-positive myocytes, regardless of drug treatment. Quan-
titation of these observations (Table 1) confirms that a normal
microtubule (re)organization is not necessary for that of the other
systems. In fact, pericentrin reorganization appeared specifically
enhanced by taxol and nocodazole. Thus, pericentrin, Golgi
complex and ERES may follow different pathways when
reorganizing. We observed GM130 reorganization only in cells
with reorganized pericentrin (Figures 2 and S3), thus pericentrin
reorganization appears upstream of the Golgi complex reorgani-
zation.
We observed three levels of Golgi complex reorganization: (I)
completely reorganized, i.e. fragmented into elements positioned
along the nuclear envelope (Figure 2A, D); (II) partially
reorganized (Figure 2B, E); or (III) not at all reorganized
Figure 1. C2 cells initiate differentiation and reorganize
pericentrin despite chronic treatment with microtubule-dis-
rupting drugs. Cells differentiated in the presence of 50 nM taxol,
100 nM DW12 or 200 ng/ml nocodazole (see Methods) were stained for
myogenin (green), a differentiation marker, and pericentrin (red), a
centrosomal protein. Myogenin-positive cells show characteristic
perinuclear pericentrin belts (insets) despite incomplete elongation,
inhibition of fusion and enlarged nuclei (taxol and nocodazole). Wide-
field images. Bars: 25 mm and 5 mm (insets).
doi:10.1371/journal.pone.0029057.g001
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agreement with its known effects, but taxol and DW12 did not.
DW12 treatments frequently resulted in pericentrin and Golgi
elements at the two poles of the nuclei (Figure 2G), a rare
distribution in control cells. This polar distribution was even found
in cells in which most of the Golgi complex failed to fragment
(Figure 2H). Quantitation (Table 2) shows that Golgi complex
redistribution is not as complete as pericentrin redistribution in
treated cells. Golgi complex reorganization is thus more affected
by each treatment than pericentrin reorganization.
We previously proposed that ERES determine Golgi complex
localization [24] and we therefore monitored any uncoupling of
the two. ERES and Golgi complex redistributions were very
closely linked (Figure 2I–N) and this relationship was not
significantly affected by microtubule alterations (Table 2). Even
abnormally localized Golgi complex was surrounded by ERES
(arrows in Figure 2I–K). Only occasional myocytes showed
GM130 reorganization with a poor or non-existent Sec31
reorganization. Therefore it appears that Golgi elements do not
need microtubules to be associated with and localized next to
ERES. Although we routinely used 200 ng/ml of nocodazole, we
also tested concentrations up to 2000 ng/ml and pre-treatment
with cold, with similar results (Figure S4).
Thus we find that the redistribution of centrosome, Golgi
complex, and ERES only takes place in myogenin-positive cells
and that pericentrin reorganization is upstream of the other
components. The redistributions can take place in the absence of
dynamic microtubules indicating that these are not essential.
However, microtubule manipulations reduce the occurrence of
fully normal reorganizations, and this affects the Golgi complex
and the ERES more than pericentrin.
Trafficking of cargo is intact in cells with mislocalized
Golgi complex
As the drug treatments affected both the structure and
positioning of Golgi complex and the microtubules normally
needed for Golgi complex function, we next assessed their
functional consequences, i.e. cargo traffic (Figure 3). We
concentrated on DW12-treated cells, as these had both recogniz-
able Golgi complexes and microtubule networks (requirements for
secretory traffic), even if altered. We used the model cargo VSV-
Figure 2. Reorganization of Golgi complex and ERES also takes place in cells treated with microtubule-altering drugs. (A–H) C2
cultures treated as described in Figure 1 were stained for pericentrin (pc, red) and GM130 (green) or (I–N) for GM130 (green) and Sec31 (red), an ERES
marker. Only cells with redistributed pericentrin are shown here. In the absence of pericentrin redistribution there is no redistribution of GM130 or
Sec31 (not shown here). In taxol- and nocodazole-treated cells, we find different degrees of Golgi complex reorganization: full (A, D); partial (B, E);
none (C, F). In DW12 (G–N), Golgi fragment localization is polarized (G, H) or fragmentation is incomplete (H). Most ERES are associated with Golgi
complex elements regardless of treatments (I–K; arrows). Rare cytosolic ERES clusters without Golgi elements are observed in the cytoplasm (L–N,
arrowheads). Wide-field images. Bars: 20 mm.
doi:10.1371/journal.pone.0029057.g002
Table 1. Quantitation of redistribution of pericentrin, Golgi
complex and ERES in myogenin-positive cells after
differentiation in microtubule-altering drugs.
control taxol nocodazole DW12
Perinuclear pericentrin 48677 6 612* 7862* 4766
Perinuclear GM130 48655 1 694 6 612 4768
Perinuclear Sec31 47683 7 615 53614 37610
Percentage of total population 6 s.d. Significant differences (unpaired
Student’s t-test):
*p,0.05.
doi:10.1371/journal.pone.0029057.t001
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of the vesicular stomatitis virus G protein. Its trafficking kinetics
have been documented in several mammalian cell types, including
muscle [42,43,44,45]. VSV-G accumulated in the ER at 40uC and
was released in both control cells and DW12-treated cells after
shifting to 32uC. It reached the Golgi complex after 10 minutes at
32uC and the plasma membrane after 30 minutes. After one hour,
the majority of the VSV-G was on the plasma membrane in
control and DW12-treated cultures (Figure 3A). The timing of
trafficking was very similar to published reports for COS-7 cells
[46,47]. Quantitation showed remarkably little difference between
controls and DW12-treated undifferentiated cells, indicating that
mislocalized Golgi complexes fully participate in VSV-G traffic
(Figure 3B). The only observed effect of DW12 treatment was a
slight delay in clearing VSV-G from the Golgi complex in
differentiated cells. These results indicate that even mislocalized
Golgi complexes linked to abnormally stabilized microtubules can
support normal cargo trafficking.
Developmental stage, not treatment length. predicts
success of microtubule recovery after nocodazole
treatment
It is conceivable that the Golgi complex reorganization would
normalize if nocodazole were washed out after differentiation,
assuming that microtubules then would regain the distribution
normally found in differentiated muscle cells. We thus removed
nocodazole after the usual three-day treatment, and assessed
recovery of microtubules (Figure 4). Microtubule regrowth was
fast: a complex network was already visible after three minutes
(Figure 4A). The presence of these microtubules however did not
improve reorganization of the pericentrin or the Golgi complex.
The fraction of cells with perinuclear pericentrin was not modified
and Golgi complex reorganization was only partially improved
(Figure 4B, C). However, the reformed microtubule network
differed from both myoblast and myotube normal networks. It
contained numerous nodes as if it resulted from nucleation on
dispersed sites. Indeed, in cells fixed just before nocodazole was
washed out, we observed short residual microtubules, each
connected to a pericentrin dot, and each containing Glu-tubulin
(Figures S2 and 4D). It looks therefore as if nocodazole washout
lets microtubules rapidly reform by elongation from these short
residual microtubules. The dispersal of pericentrin to these many
short microtubules was found in all nocodazole-treated myoblasts
(myogenin-positive or not), but not in untreated cells or in cells
treated with taxol or DW12. After 6 hours of recovery from
nocodazole, the microtubule network did not show further
changes. To assess whether the abnormal recovery is simply due
to the length of the treatment with nocodazole (72 hours), we
subjected normally differentiated myotubes to the same 72-hour
nocodazole treatment. At the end of this treatment, the myotubes
had lost their elongated shape (Figure 5A, D). But when
nocodazole was washed out, recovery of the cell shape and of a
normal-looking microtubule network was complete in 24 hours
(Figure 5I). Nocodazole also caused all but small pieces of
microtubules to disappear (Figure 5E, F). But unlike in cells
differentiating in nocodazole, many short microtubules and some
Glu-tubulin staining were concentrated around the nuclei
(Figure 5B, H). Perhaps more importantly, pericentrin
(Figure 5C) and Golgi elements (Figure 5G) remained positioned
around the myotube nuclei. Thus, when differentiation occurs in
nocodazole, some irreversible changes affect microtubules. These
changes are likely responsible for the incomplete or imperfect
redistribution of centrosomal and Golgi complex proteins.
During normal differentiation, pericentrin relocates
gradually and provides a platform for microtubule
nucleation, Golgi complex and ERES
Some rapid cellular events that depend on microtubules, i.e.
mitosis, involve a breakdown of existing structures (the normal
microtubule network) and de novo buildup of another one (the
mitotic spindle). The events are regulated by a cascade of signaling
events but are not regulated at the transcriptional level.
Myogenesis, in contrast, is largely regulated at the transcription
level. However, the specific events we are interested in appear
gradual. To find out which scenario is involved in organelle
redistribution, we searched for cells with partial reorganization of
the organelles in untreated cultures (Figure 6A, B). We did find,
early in differentiation, elongated cells with a partial nuclear cap of
pericentrin emanating from the centrosome (Figure 6C). These
cells represent a constant fraction of the myogenin-positive
population (Figure 6E, F), as expected from cells entering and
leaving a transitional state at similar rates in unsynchronized
cultures. In contrast, a steady increase in the number of cells with
the partial phenotype would indicate failed progression of
differentiation. Even partial nuclear pericentrin caps supported
microtubule nucleation (Figure 6D).
Golgi complex reorganization appeared progressive as well
(Figure 7A). However, pericentrin expanded more rapidly to a
larger domain than the Golgi complex. Furthermore, 3D
reconstruction revealed that pericentrin does not form a belt as
usually referred to, but a complete shell around nuclei (Figure 7A,
C). GM130 was found in different patterns, from partial belts
(Figure 7B) to full shells (Figure 7C). The latter became
predominant only in multinucleated cells (see quantitation,
Figure 7D).
To determine if ERES guide Golgi complex reorganization, as
postulated in our model [24], we searched for mismatch between
ERES and Golgi complex in transitioning cells. A partial GM130
belt was found as frequently with as without perinuclear ERES
Table 2. Quantitation of relationship between pericentrin and Golgi complex redistribution, and between Golgi complex and ERES
redistribution in cultures grown and differentiated in the presence of microtubule altering drugs.
control taxol nocodazole DW12
Cells with perinuclear pericentrin
that also had perinuclear GM130 (%)
84635 8 610* 6367* 6368*
Cells with perinuclear GM130 that
also had perinuclear Sec31 (%)
98618 6 699 4 619 3 61
Percentage of total population 6 s.d. Significant differences (unpaired Student’s t-test):
*p,0.05.
doi:10.1371/journal.pone.0029057.t002
Microtubules and Organelles during Myogenesis
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e29057clusters (Figure 7E) but perinuclear ERES clusters without a
perinuclear Golgi complex belt were not observed.
Quantitative PCR (Figure 8A) demonstrated that centrosome
and Golgi complex mRNA changes are two to three orders of
magnitude smaller than changes in myogenin mRNA. In addition,
we found no differentiation-related shift between the isoforms of
pericentrin (A and B or kendrin [48]). At the protein level as well,
changes in centrosomal and Golgi complex proteins are modest
compared to those for myogenin (Figure 8B, C). We conclude that
myogenic reorganization of the centrosome and Golgi complex
involves a gradual transformation and relocation of the organelles.
Microtubules constantly nucleate from myotube nuclei
We have proposed a model [24], which explains the presence of
the Golgi complex around the myotube nuclei by the coalescence
of the microtubule nucleation sites and of the ERES. Newly
formed pre-Golgi complex vesicles that emerge from the ERES
and normally move retrogradely to microtubule minus ends, stay
put since they are already at the microtubule minus ends. But this
model hinges on microtubules constantly nucleating from the
nuclear envelope area [24,49] and this has not been shown in
unperturbed myotubes. We and others have previously identified
the nuclear membrane area of myotubes as a bona fide
microtubule nucleation site only during recovery from complete
depolymerization [49,50]. The high density of microtubules in
unperturbed cells hampers tracing their origin.
We now use a GFP chimera of the microtubule plus-end protein
EB3 to observe microtubule dynamics in live muscle cells
(Figure 9). In myoblasts, EB3-GFP puncta move outward in the
well-known fountain-like pattern, at the maximum frequency of 32
Figure 3. Mislocalized Golgi complex supports normal cargo trafficking. Control and DW12-treated cells were transfected with cDNA for
VSV-G-ts045-YFP, held at 40uC to keep VSV-G in the ER and switched to 32uC to allow cargo trafficking to the plasma membrane through the Golgi
complex. (A) Differentiated cells fixed at the indicated time after switching to 32uC were stained with anti-GM130 (red) while VSV-G is shown in green.
Each image is the projection of a confocal z-stack; DW12 treatment does not affect the timing or pattern of cargo transport. Bar: 20 mm. (B)
Quantitation of cargo locations. For each time point, the location of VSV-G-ts045-YFP was determined in 100 cells (represented by dots). In
differentiated cells, DW12 delays cargo clearance from the Golgi complex slightly, but cargo eventually reaches the plasma membrane in control and
DW12 cells alike.
doi:10.1371/journal.pone.0029057.g003
Microtubules and Organelles during Myogenesis
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100 seconds; Figure 9A,B, Movie S1). In myotubes, in contrast
(Figure 9A, B, Movie S2), EB3-GFP puncta have no concerted
movement, in agreement with the published behavior of EB1 [51].
Rather, EB3-GFP puncta move toward the plasma membrane and
toward the myotube ends, often crossing paths. We were able to
track EB3 puncta originating from myotube nuclei (Figure 9C).
The maximum number of puncta observed per 100 seconds per
nucleus was 10 (range: 1–10 per 100 seconds, Figure 9B). Thus
there is steady-state microtubule nucleation at the myotube
nuclear envelope. Trajectory analysis showed that some cytosolic
spots repeatedly produce EB3 puncta. These spots probably
represent centrosomal remnants, nucleation-competent cytoplas-
mic elements containing a centriole and centrosomal proteins [49].
To determine whether steady-state nucleation at the nuclear
membrane is associated with Golgi elements, EB3-GFP and the
Golgi marker GalT-mCherry were co-transfected. GalT-mCherry
faithfully targets the Golgi complex in myotubes, as verified by
anti-giantin staining (Figure 10A). If Golgi elements nucleate
microtubules, EB3-GFP trajectories should start from GalT-
mCherry-labeled Golgi stacks. As shown in Figure 10B–D and
Movie S3, this was not the case. Microtubule nucleation was
observed from areas not labeled with Galt-mCherry.
The number of EB3 puncta originating from myotube nuclei in
unperturbed cells appeared modest when compared to the density
of small microtubules observed after recovery from complete
microtubule depolymerization [49,50]. To understand this
difference, we imaged EB3-GFP expressing cells on a confocal
microscope at 37uC throughout nocodazole treatment and
recovery. Unlike myoblast centrosomes which produce a burst of
EB comets immediately following washout (Figure 11A, Movies S4
and S5), myotube nuclear membranes, in the same experimental
conditions, do not show comets emerging from the nuclear rim
(Figure 11B, Movies S6 and S7). Moreover, comets could only be
found after several minutes of recovery,and in the cell periphery.
Quantitation of EB fluorescence showed that the myoblast
centrosomal area becomes transiently brighter after washout while
myotube nuclear areas do not (Figure 11C, D). To rule out that
the lack of EB comets in myotubes is due to the GFP tags on the
EB proteins, we examined untransfected cells fixed 5 minutes after
nocodazole washout and stained with anti-EB1 or -EB3. We found
abundant EB1 or EB3 around the centrosomes of myoblasts, but
practically none at myotube nuclear rims (Figure 11 E). Since EB1
is normally in constant exchange between microtubules and
cytosol, we wanted to rule out that this exchange, possibly
accelerated in myotubes, explains the absence of EB staining
during microtubule recovery. A pre-fixation protocol combining a
brief detergent extraction with taxol to stabilize EB proteins and
preserve the accurate state of the in vivo microtubule assembly (see
Methods and [52]) allowed us to visualize small newly nucleating
microtubules and EB1 simultaneously, 5 minutes after nocodazole
washout (Figure 11F). Both myotubes and myoblasts show many
small microtubules (Figure 11F middle panel). A weak signal along
the nuclear membrane of the myotubes indicates the presence of a
small amount of EB1, but the staining remains much weaker than
in myoblasts.
Thus we have demonstrated that nucleation of microtubules
from the nuclear membrane of myotubes is constant, and we have
uncovered an unexpected lack of EB proteins on small
microtubules emerging at the earliest times after removal of
nocodazole.
Discussion
It has been difficult, so far, to detect a hierarchy in the different
reorganizations that take place during myogenesis because they
Figure 4. Fast but abnormal recovery of microtubules in cells kept in nocodazole 72 hours through differentiation. After three
minutes washout from chronic nocodazole treatment (A), there are abundant microtubules but their pattern is different from that in either myoblasts
or myocytes. Quantitation of the redistribution of pericentrin (B) and Golgi complex (C) after recovery (co: control; nz: no recovery; rec: 6 hours
recovery). Pericentrin redistribution is unchanged, while Golgi complex organization is improved but does not reach the level observed in control
cells. Without washout (D), there are residual short microtubules, many of which contain Glu-tubulin (upper row, with inset). Pericentrin (lower row) is
found around the nuclear envelope and in the cytoplasm. The selected cell, which has distinct, albeit very little relocation of pericentrin, also has a
cytoplasmic pericentrin pool that consists of a few strongly stained dots at the center of microtubule asters and of many small dots that decorate one
end of the short microtubules (inset). Nuclei are counterstained with Hoechst (blue). Main panels: confocal z-stack projections; inserts: individual
optical sections. Bars: 5 mm.
doi:10.1371/journal.pone.0029057.g004
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uncouple them by challenging the cells to differentiate in the
presence of drugs that affect microtubules. We find that each of
the subcellular systems we examine, i.e. centrosome (MTOC),
Golgi complex, and ERES, is able to relocate despite microtubule
alterations. We also find that the relocation of the centrosomal
proteins paves the way for the relocation of the other systems.
Furthermore, centrosomal proteins reorganize more completely
than Golgi complex and ERES sites in the absence of a dynamic
microtubule network. We conclude that direct transport along
dynamic microtubules is not involved in the transfer of
centrosomal proteins to the nuclear envelope, but that it plays
some role in Golgi complex and ERES reorganization.
Some of the cells that differentiate in microtubule-affecting
drugs reach a state of partial organelle redistribution. We could
not improve the outcome by washing the drug away. This
experiment concentrated on nocodazole treatment, because its
effects are known to be reversible within a matter of minutes to
hours. Less is known of reversal of the effects of taxol and DW12.
Our observations highlight irreversible changes that affect the
reciprocal relations between organelles and microtubules during
myogenesis.
Figure 5. Full recovery of microtubules in cells kept in nocodazole 72 hours after differentiation. Cells were differentiated into
myotubes and only then treated with 200 ng/ml nocodazole for 72 hours. At the end of the treatment (A–H), myotubes (outlined in red dotted lines)
have lost their elongated shape (A, D) and only contain short microtubules located along the nuclear membranes (B), and in the cell periphery (E).
Many of the microtubules contain Glu-tubulin (F). Glu-tubulin is also found in dots along the nuclear envelope (H). Pericentrin (C) and Golgi elements
(G) remain localized around the myotube nuclei. Panels (B) and (C) show details from the boxed area in (A); (E) and (F) show details from the boxed
area in (D). After 24 hours washout from nocodazole, myotubes are elongated again and have re-established a normal microtubule network (I).
Staining patterns for Glu-tubulin (left), pericentrin (middle) or GM130 (right) are undistinguishable from those in untreated myotubes. Images are
single confocal optical sections. Bars: 10 mm.
doi:10.1371/journal.pone.0029057.g005
Microtubules and Organelles during Myogenesis
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which Golgi complex fragmentation and reorganization during
myogenesis involve microtubule-dependent retrograde trafficking
through the ER, whereas centrosomal proteins move from
centrosome to nuclear membrane through a more direct,
microtubule-independent path. Our model also predicted that
ERES relocate ahead of and guide the Golgi complex. We have
not been able to prove this because microtubule manipulations did
not uncouple them sufficiently. The observation of a few cases
when one reorganized without the other suggests that ERES
redistribute independently of the Golgi complex, possibly
consolidating around ER areas rich in Golgi complex enzymes,
in agreement with Guo and Linstedt [53]. ERES fusion and fission
have been studied extensively [54] but ERES positioning is poorly
understood because no other cell types that we know of show
specific ERES localization in physiological conditions.
Redistribution of centrosomal proteins is enhanced rather than
impeded by treatment with nocodazole and taxol. Since dynein is
necessary to bring pericentrin and c-tubulin to centrosomes
[28,29,55], nocodazole may free the two proteins from the
MTOC, possibly explaining how pericentrin dots come to
decorate one end of the short microtubules that remain in the
Figure 6. Pericentrin reorganization to the nuclear envelope is gradual. After one day in FM, C2 cultures contain: (A) undifferentiated cells;
(B) myocytes with a small pericentrin dot attached to a perinuclear pericentrin belt and longitudinal microtubules; (C) myocytes with a partial
pericentrin belt (arrows) and partially remodeled microtubule network. (D) In such cells, microtubule regrowth after complete depolymerization
(inset) originates from the partial pericentrin belt. Images are single confocal sections for pericentrin (green) and z-stack projections for tubulin (red).
Nuclei are counterstained with Hoechst (blue). Bars: 10 mm; inset: 5 mm. (E) Quantitation of pericentrin morphologies in differentiating cultures and
(F) correlation between myogenin expression and pericentrin distribution.
doi:10.1371/journal.pone.0029057.g006
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similarly enhances redistribution of centrosomal proteins but
DW12 treatment, which inhibits GSK3-b, does not. Both taxol
and DW12 stabilize microtubules, but the extent and pattern of
stabilization differ. In addition, GSK3-b has been indirectly linked
to microtubule anchoring at the centrosome through its control of
Figure 7. Pericentrin and GM130 reorganize coordinately but occupy distinct domains. (A) During the transition to the differentiated
phenotype, GM130 and pericentrin show a similar degree of partial reorganization. (B) Orthogonal views of a myocyte show a full pericentrin shell
around the nucleus while GM130 is limited to the equatorial plane. (C) 3D rendering of pericentrin and GM130 in a myocyte (top) and a myotube
(bottom). (D) Quantitation of Golgi complex phenotypes in cells with pericentrin shells. (E) ERES clearly clustered at the nuclear envelope (top row),
are colocalized with Golgi fragments, but Golgi fragments are found equally with or without ERES clusters (bottom row). The images are confocal
optical sections, except for the last row in A (projections of confocal z-stacks). Bars: 5 mm.
doi:10.1371/journal.pone.0029057.g007
Figure 8. Centrosomal protein and Golgi complex reorganizations do not involve global mRNA or protein level changes. (A) RT-qPCR
shows decreases in mRNAs for pericentrin, kendrin, and GM130 during differentiation which are very small compared to the increase in myogenin
mRNA. (B) Western blot analysis with anti-pericentrin produces two bands in myoblast and three in myotube homogenates, whereas anti-kendrin (or
pericentrin B) recognizes one band, stronger in myotubes. In the pericentrin blot we thus identify the 240 kDa band as pericentrin A, and the 380 kDa
band as kendrin. We have not identified the 300 kDa band. Individual blots again GM130 show small changes when compared to the increase in
myogenin, while a-mannosidase II (manII), which is absent from adult muscle, shows an expected decrease. (C) Immunoblot quantitation: values from
three independent experiments were averaged, normalized to those for cells in GM (6 s.d) except for mannosidase (done once).
doi:10.1371/journal.pone.0029057.g008
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ninein transport to the centrosome [56].
In the present work, we have also clarified key aspects of the
organelle reorganization in normal cells. We show that MTOC
reorganization is dependent on myogenin expression and is
upstream of and essential for Golgi complex reorganization. We
also show that reorganization is progressive, and that even small
patches of centrosomal proteins along the nuclear membrane can
support microtubule growth and attract the Golgi complex
(Figure 5 and [50]). Pericentrin therefore determines or at least
identifies a domain of the nuclear membrane competent for
microtubule nucleation, Golgi complex and ERES localization.
This correlation persists through muscle maturation since Golgi
elements in muscle fibers are associated with concentrations of
pericentrin [25,26] at the nuclear poles and in the cytoplasm
(Oddoux et al., in preparation). We also noticed that pericentrin
forms a full perinuclear shell in myocytes. This possibly occurs by
self-assembly as suggested by Srsen et al. [43], and would explain
pericentrin’s independence from normal microtubule organiza-
tion.
Quantitative PCR and immunoblotting experiments indicate
that relocation of the organel l e sd u r i n gm y o g e n e s i sd o e sn o t
involve transcriptional or translational activation of the genes
involved and must therefore be regulated post-translationally.
For pericentrin at least we expected significant changes at the
protein level. Immunofluorescence gives the impression of a
vastly expanded staining when comparing the small centrosome
to the full perinuclear shell, but changes during differentiation
in the amount of pericentrin and its message are in fact small.
We ruled out that differentiation involves a switch from
pericentrin to kendrin (pericentrin A and B, respectively) and
did not detect pericentrin S, an isoform predicted from RNA
analysis to be abundant in muscle [48,57] but never actually
reported.
Figure 9. EB3-GFP tracking reveals microtubule nucleation from the nuclear membrane of myotubes at steady-state. (A) Single
frames from time-lapse recordings of EB3-GFP in a myoblast (Movie S1) or in a myotube (Movie S2). The arrow in (A) points to the centrosome. (B)
Quantitation: we measured 22.466.4 nucleations per 100 seconds for centrosomes (n=10), and 5.462.2 per 100 seconds per nucleus for myotubes
(n=28). (C) Details from a myotube recording showing EB3 puncta (outlined in red) moving away from a nucleus (asterisk marks the initial location of
the punctum). Bars: 5 mm.
doi:10.1371/journal.pone.0029057.g009
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including ours [1,49,50], have investigated this process only during
recovery from microtubule depolymerization. For most cells this is
justified, since the microtubule pattern during recovery is similar
to that at steady-state, but in myotubes this is not the case. We
show, for the first time, that microtubules constantly originate
from the nuclear membrane of myotubes at steady-state. This is
important because it explains the Golgi complex localization
around the nucleus. Nucleation from myotube nuclei is less
frequent than from centrosomes, even after taking into account the
much larger nuclear surface. Furthermore, we have uncovered a
basic difference between myotubes and myoblasts (and, conse-
quently, other proliferating cells) during recovery from microtu-
bule depolymerization. The short microtubules reforming around
myotube nuclei appear initially devoid of the plus-tip proteins EB1
and EB3, unlike microtubules reforming from centrosomes.
Centrosomes contain EB proteins [58] whereas nuclear mem-
branes have not been shown to accumulate them. In myotubes, EB
proteins must therefore be recruited from the cytoplasmic pool to
the newly forming microtubules along the nuclear membrane. In
myoblasts, EB proteins are immediately available to the forming
microtubules. EB proteins are considered core components that
link other plus-tip proteins to microtubules (see [59]). We are not
aware of another situation in which newly forming microtubule
plus-tips contain neither EB1 nor EB3. We conclude that there are
structural and functional differences between centrosomes and
unconventional MTOC, a difference relevant to several non-
muscle cell types as well.
Time-lapse recordings of EB3-GFP in myotubes give at first an
impression of random movement, but there are also repetitive
trajectories and crossing points (Movie S2), suggesting that EB3-GFP
labels individual microtubules growing along stationary bundles.
Golgi complex elements were occasional but not sole sources of
microtubule nucleation at the nuclear envelope, indicating that Golgi
elements are positioned at the nuclear membrane because of
microtubule nucleation rather than the reverse.
In addition to the traditional nucleation and anchoring
observed in myoblasts, other processes may take place in myotubes
such as anchoring after nucleation at another site [33] and
regrowth of microtubules from existing stable tubulin seeds [60].
Regrowth from existing seeds seems the most likely explanation for
the short Glu-tubulin-containing microtubules depicted in
Figure 4D.
Uncoupling subcellular changes taking place during muscle
differentiation has allowed us to establish centrosome/MTOC
reorganization as the first step of the systems that we monitored
and to show that the changes are remarkably resistant to
microtubule disruptions. Finding out how pericentrin and other
MTOC components in muscle are linked to nuclei is one of the
most interesting questions ahead. It seems likely that transmem-
brane proteins of the nuclear membrane, such as the nesprins
(reviewed in [61]), which mediate interactions between centro-
some and nucleus, must be involved.
Changes in Golgi complex morphology or placement are
automatically assumed to affect function negatively. Here we
show, however, that mislocalization caused by treatment with a
GSK3-b inhibitor barely slows down cargo trafficking, an essential
Golgi complex function. Rahkila et al. [43] reported that VSV-G
is retained in an intracellular compartment after muscle cell
differentiation. We did not observe such retention, perhaps
because of differences in the experimental conditions: Rahkila
et al. [43] used full virus infection to express VSV-G in L6 cells,
whereas we used cDNA transfection to express VSV-G in C2
myoblasts and myotubes.
Microtubules play structural roles in muscle-specific events such
as myoblast elongation, fusion or sarcomere formation [62,63,64]
and they are essential to differentiation [65,66]. They also play a
role in processes that are not muscle-specific but are important in
muscle, such as macroautophagy [22,23]. The fact that we find only
minor defects in cargo trafficking when microtubule organization is
altered and the Golgi complex is mislocalized, suggests that cells can
tolerate some level of disturbance of microtubules and related
organelles. This would be good news for conditions such as Pompe
disease, or Duchenne Muscular Dystrophy, in which Golgi complex
and microtubules are affected [18,19].
Materials and Methods
Antibodies and Reagents
Mouse anti-GM130 antibodies were from Transduction Labs
(Lexington, KY), anti-giantin from Covance (Denver, PA), anti-
Figure 10. No obligatory relationship between microtubule
nucleation and Golgi complex fragments along the myotube
nuclear membrane. (A) GalT-mCherry colocalizes with the Golgi
marker giantin (projection of a confocal z-stack). (B) Single frame from
time-lapse recordings of EB3-GFP (green) and GalT-mCherry (red) in a
doubly transfected myotube (Movie S3). (C, D) EB3 puncta (outlined in
white) moving away from a nucleus (delineated by dotted line). The
starting point of the punctum (star) in (C) is near but distinct from a
Golgi element (arrow) while in (D) the punctum starts from a Golgi
element. Boxes in (A) indicate areas enlarged in C, D. Bars: 5 mm.
doi:10.1371/journal.pone.0029057.g010
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Abcam (Cambridge, MA), anti-a-tubulin and anti-c-tubulin from
Sigma (St. Louis, MO) and rabbit anti-detyrosinated tubulin from
Millipore (Billerica, MA). Rabbit anti-pericentrin and anti-giantin
were from Covance, and anti-GAPDH from Novus (Littleton,
CO). The following antibodies were generous gifts: rabbit anti-a-
mannosidase II (Dr. K. Moremen, University of Georgia, Athens,
GA), rabbit anti-Glu-tubulin (Dr. G. Cooper IV, Veterans
Administration Medical Center, Charleston, SC), chicken-anti-
kendrin (Dr. T. Davis, University of Washington, Seattle, WA),
Figure 11. Timelapse recordings of EB1- or EB3-GFP highlight differences between myoblasts and myotubes after washout from
acute nocodazole treatment. Myoblasts and myotubes expressing EB1-GFP were imaged before, during, and after treatment with nocodazole
(1 hour, 5 mg/ml). (A) In myoblasts, EB1-GFP comets are present before treatment (A, Pre), absent during nocodazole treatment (not shown) and at
the start of washout (A, t=1 min). Over the next several minutes, EB1-GFP accumulates in the centrosomal region (A, t=5.5–8 min). When the return
of EB1-GFP comets throughout the cytosol indicates the restart of steady-state microtubule growth, the level of EB1-GFP at the centrosome returns to
its initial value (A, t=13 min). (B) There is no such increase in the EB1-GFP concentration at myotube nuclear rims, despite the return of EB1-GFP
comets in the cytosol at 6.5 minutes (see detail of boxed area), indicating that microtubule growth has commenced. (C) Analysis of the level of EB1-
GFP in the areas outlined in red in the images shown in A (black) and B (red). (D) Quantitation of EB1-GFP and EB3-GFP levels after nocodazole
washout in myoblast centrosomes and myotube nuclear rims. (E) To exclude that the results in B are due to problems with the GFP-tagged
constructs, the same treatment was carried out on untransfected cultures. Five minutes after nocodazole washout, cells were fixed and stained for
EB1 and EB3. Again, neither accumulates at myotube nuclear rims (arrowheads), while both are prominent at myoblast centrosomes (arrows). (F)
When a microtubule stabilization protocol combining detergent extraction and taxol is used before fixation, only very weak EB1 staining is found
near myotube nuclear rims (arrowheads), despite the presence of many short microtubules in this location. Bright staining is present at centrosomal
regions (arrows) and on small microtubules in myoblasts’ cytoplasm. (E, F: dashed lines outline myotubes). Bars=5 mM (main panels), 1 mM (detail).
doi:10.1371/journal.pone.0029057.g011
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School of Medicine, New Haven, CT). Alexa488- and Alexa568-
conjugated secondary antibodies were purchased from Invitrogen
(Carlsbad, CA). HRP-conjugated anti-mouse and anti-rabbit IgG
were from Bio-Rad (Hercules, CA) and HRP-conjugated anti-
chicken IgY, together with BlockHenII, were from Aves Labs, Inc.
(Tigard, OR). Hoechst 33342, nocodazole and taxol were from
Sigma. DW12 was a kind gift from Dr. E. Meggers (University of
Pennsylvania, Philadelphia, PA).
Cell culture and drug treatments
Mouse C2 skeletal muscle cells were cultured in growth medium
(GM) and differentiated in fusion medium (FM) as described [24].
Drugs were added 4 hours after plating to achieve 200 ng/ml
(0.66 mM) nocodazole or 50 nM taxol. In some experiments cells
were placed on ice for 30 minutes after the addition of nocodazole
and then warmed up to at 37uC in the drug. Because nocodazole
and taxol inhibit cell proliferation, dishes for these treatments
received twice the control cell number. For nocodazole washout,
cells were fixed or rinsed three times in PBS, and further cultured
in drug-free media at 37uC for the times indicated before fixation.
The drug DW12 was used at 100 nM. This organo-ruthenium
compound specifically inhibits GSK3-b and, like the broad
inhibitor lithium chloride, leads to local microtubule stabilization
[37,67,68].
The Mitotic Index [MI=(cells in prophase+anaphase+meta-
phase+telophase)/total cell count] of the C2 culture, calculated on
3 separate samples of 400 cells, was 0.04260.006 (mean 6
standard deviation, s.d.).
Immunofluorescence and microscopy
Cells were fixed in 100% methanol at 220uC for 6 minutes,
blocked in PBS containing 1% bovine serum albumin, 2% horse
serum and 3% normal goat serum for one hour, incubated with
primary antibodies for 1–2 hours, and with secondary antibodies
for 45 minutes (all at room temperature), counterstained with
Hoechst 33342, and mounted in Vectashield (Vector Laboratories,
Burlingame, CA) or in home-made mounting media consisting of
p-phenylenediamine in 80% glycerol. Wide-field immunofluores-
cence images were collected on a Leica DMR, using a 6361.32
N.A. oil immersion objective lens and a Hammamatsu C4742-95
camera driven by IVision software (BioVision Technologies,
Exton, PA). Confocal images were collected either on a Zeiss
510 LSM using a 6361.4 N.A. oil immersion objective lens and
multi-track configurations, or on a Leica SP5 confocal microscope
with a 6361.4 N.A. oil immersion objective lens, using sequential
scanning. The figure legends specify whether images are single
optical planes or projections of stacks of optical sections
throughout the cell (z-stacks). Images were exported in 8-bit TIF
format and linearly adjusted using Adobe Photoshop.
Quantitation of reorganization
To assess the effect of a range of nocodazole concentrations on
subcellular organization, cells were grown for 48 hours in GM and
differentiated in FM for 24 hours with the indicated concentration
of nocodazole. Images were collected every two hours using an
IncuCyte image system (on a kind loan from Essen Instruments,
Ann Arbor, MI). Cell confluence was plotted using the
manufacturer’s software. Since C2 cells kept in microtubule-
disrupting drugs fuse poorly, we analyzed differentiated but
unfused cells (myocytes), even in control cultures. For Tables 1
and 2, we scored 600 myogenin-positive cells per time-point for
the presence of perinuclear staining (belt), by observation on a
wide-field microscope. Cells with the majority of the marker in a
perinuclear belt were classified as reorganized. Cells with the
marker divided between perinuclear belts and additional locations
were classified as partially reorganized. Cells without perinuclear
belts were classified as not reorganized. In the next step, cells with
reorganized pericentrin were selected and analyzed for Golgi
complex morphology. Finally, cells with reorganized Golgi
complex were analyzed for reorganization of ERES. Data are
expressed as means 6 s.d. An unpaired Student’s t-test was used
for statistical analysis (Excel software). For analysis of reorganiza-
tion after nocodazole washout, 400 cells in two independent
experiments were analyzed for the presence of perinuclear
pericentrin or GM130. The analysis of pericentrin reorganization
in control cultures (Figures 5 and 6) was done in 200 myogenin-
positive and 200 myogenin-negative cells at each indicated time
point. Additionally, confocal z-stacks were collected of cells with
reorganized pericentrin (one day in FM), and in those, the
morphology of the Golgi complex was classified using 3D
renderings in Imaris software (Bitplane, Saint Paul, MN).
Microtubule Nucleation Assay
Cells were incubated in 5 mg/ml nocodazole on ice for
30 minutes to sever microtubules and then at 37uC for 30 minutes
to depolymerize microtubules completely. To regrow microtu-
bules, cells were quickly rinsed twice in warm PBS and incubated
for the indicated times in GM or FM at 37uC. For better
visualization of the regrowing microtubules, cells were extracted at
room temperature for one minute in PHEM buffer (60 mM
piperazine-N,N-bis-2-ethanesulfonic acid, 25 mM HEPES,
10 mM EGTA, 2 mM MgCl2, pH 6.9) containing 1% Triton
X-100 and rinsed in PHEM buffer for 20 seconds before fixation.
For visualization of both EB proteins and small microtubules right
after nocodazole washout, cells were incubated for one minute in
4 mM taxol in a buffer containing 0.5% Nonidet P-40, 20 mM
Tris HCl, 140 mM NaCl, 1 mM MgCl2, 2 mM EGTA (pH 6.8
[52]) at RT before fixation.
Cell homogenates and Western analysis
Cells growing on Petri dishes were trypsinized, collected by
centrifugation, washed twice, and taken up in sample buffer
(National Diagnostics, Atlanta, GA). The samples were assayed for
protein concentration (Pharmacia 2d Quant kit, Peapack, NJ);
proteins were separated on pre-cast tris acetate or bis-tris gradient
gels (Invitrogen) at 100 V for one hour or at 200 V for 35 minutes
and transferred to nitrocellulose membranes at 51 V for 4 hours
or at 20 V overnight at 4uC. The membranes were blocked in 5%
milk powder in TBS for one hour (except for 2% FBS and 1%
NGS in TBS for a-mannosidase II, or 7.5% BlockHen, 5% NGS
in PBS for anti-kendrin), incubated with primary antibodies for
two hours and with HRP-conjugated secondary antibodies for one
hour at room temperature. The peroxidase activity was revealed
with Pierce Supersignal West (Rockford, IL) and captured on
Kodak BioMax MR film (Rochester, NY). Films were scanned on
a UMAX scanner (Dallas, TX) and band intensities were
measured with ImageJ software (written by W.S. Rasband,
National Institutes of Health, and available at http://rsb.info.
nih.gov/ij/). Molecular weights for bands on pericentrin films
were estimated using HiMark Prestained HMW protein standard
(Invitrogen). Polynomial curve-fitting of the relative migration
distances (Rf) was done in Kaleidagraph software (Synergy
Software, Reading, PA).
Quantitative RT-PCR (RT-qPCR)
Total RNA was purified using Trizol (Invitrogen) and samples
(100 ng) were reverse transcribed using High Capacity cDNA
Microtubules and Organelles during Myogenesis
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cDNA samples were diluted 10-fold and used for qPCR using
SYBR Green (Applied Biosystems). For quantitation, values were
normalized over internal control (GAPDH) and represented
relative to myoblast levels. Primers used are, 1) for sequences
shared by pericentrin & kendrin: forward 59 GTCTGTCCAG-
GAGGAGGGTTC, reverse 59 AGGTCAGTCACATCCAGTT-
CAC 39; 2) for Kendrin specific: forward 59 AACTCACTCGA-
GATGACCTTCTG 39, reverse59 GGCAAACTTCTCCATG-
ATCTCT 39; 3) for GM130: forward 59 GCCAAGAAAAAGCT-
GAGAGAGT 39, reverse 59 GGACACCAGCACCTTCAGAAT
39; 4) for GAPDH: forward 59 AACATCAAATGGGGTGAG-
GCC 39, reverse 59 GTTGTCATGGATGACCTTGGC 39.
Secretory cargo trafficking assay
Cells were plated on coverglass and DW12 (100 nM) was added
after 4 hours. After another 16 hours, the cells were transfected
with 1.2 mg of VSV-Gts045-YFP cDNA using FuGENE transfec-
tion reagent (Roche, Indianapolis, IN) and incubated for 24 hours
at 37uC. The cultures were then switched to 40uC. Control
cultures grow and fuse normally at 40uC. Some cultures were kept
at 40uC for one day, then incubated for various times at 32uC for
cargo release, and fixed (undifferentiated cultures). Others were
cultured in FM at 40uC for two days, then incubated for various
times at 32uC, and fixed (differentiated cultures). The location of
pools of VSV-G was analyzed in 100 cells per time-point, using 5
possible categories: ER, Golgi (identified by anti-GM130 staining),
plasma membrane, and a combination of these.
EB3-GFP imaging
Cells in MatTek dishes (MatTek, Ashland, MA) were
transfected one day after plating with one mg of EB3-GFP cDNA
(a kind gift from Dr. A. Akhmanova, Erasmus Medical Center,
Rotterdam, the Netherlands) using FuGENE transfection reagent.
Undifferentiated cells were imaged one day post-transfection,
differentiated cells after two days in FM. Image series of living cells
were collected at 37uC on a Zeiss 510 LSM, using a 6361.4 NA
objective, at one frame/second. Files were exported in 8-bit TIF
format, and images were processed by Kalman filtering in ImageJ.
EB3-GFP tracks were analyzed in the nuclear area of two
myoblasts (one nucleus each) and three myotubes (with combined
total of eight nuclei). In stacks of 100 frames (=100 seconds), EB3
puncta arriving at the centrosome (arrow in undifferentiated cell)
or at a myotube nucleus were counted as Na and EB3 puncta
leaving from it were counted as Nl. Each dot in the graph
represents the net number of puncta (Nl2Na).
Galactosyltransferase tagged with mCherry (GalT-mCherry)
was constructed from GalT-eGFP [14] and p-mCherry N1, a kind
gift from Dr. G. Patterson (NIBIB, NIH, Bethesda, MD).
Myoblasts were transfected with EB3-GFP and GalT-mCherry
plasmids using FuGENE and differentiated into myotubes. Time-
lapse recordings of living cells (1 frame/2 seconds) were collected
at 37uC using a Leica SP5 confocal microscope.
Analysis of EB1-GFP or EB3-GFP at centrosomes and
nuclear rims after nocodazole washout
Cells in 35 mm MatTek dishes were imaged on a Zeiss 510
Meta microscope at 37uC at one frame/second, then nocodazole
was added as a 26 stock (5 mg/ml final concentration) and the
imaging was slowed to 1 frame/5 min. After 1 hour, the dish was
washed 3 times. Imaging was restarted at 1 frame/second as soon
as the original focus level was restored. Image series were exported
as TIF files. For illustrations, images were inverted and non-linear
adjustments for brightness were made in Adobe Photoshop. To
show details of comets after the washout, images for the separate
panels were further enhanced in a non-linear manner. Intensity
changes in centrosomal regions (circular) and at nuclear rims (free-
hand shape outward about 2 mm from the edge) were quantified
with ImageJ on unprocessed files. Normalized values (to the first
frame after washout) were plotted. The maximal increases
measured for myoblast centrosomes and myotube nuclei were
plotted using Kaleidagraph. Considerable changes in the position
of the myotube nuclei, necessitating refocusing, made the myotube
curves less smooth than the myoblast curves.
Supporting Information
Figure S1 Effects of microtubule-affecting drugs on C2
cultures. (A) Optimization test for nocodazole concentration;
cultures were imaged every 2 hours. Cell proliferation is arrested
from 50 ng/ml on. (B) State of microtubules (a-tubulin, green) and
microtubule stabilization (Glu-tubulin, red) before the switch to
FM to initiate differentiation. (C) Myogenin expression in control
and treated cultures after 2 days in GM, before the switch to FM
to initiate differentiation. Wide-field images. Bar: 10 mm.
(TIF)
Figure S2 Cell shape and state of the microtubules in
C2 cells differentiated in microtubule-disrupting drugs.
Control cultures show many elongated cells and multinucleated
myotubes with longitudinal microtubules (a-tubulin, green).
Microtubule stabilization is reflected by Glu-tubulin staining
(red, arrowheads), which increases in differentiated cells. In
cultures treated with taxol (50 nM), the cells do not fuse but are
large and elongated with high levels of Glu-tubulin. DW12
(100 nM) has no global effect on the microtubule network but, in
most cells, increases Glu-tubulin next to the nucleus, and inhibits
fusion. Nocodazole (200 ng/ml) prevents both elongation and
fusion. Only very short microtubules are left, which partly stain
for Glu-tubulin. Images are confocal z-stack projections.
Outlined areas in the third column are shown enlarged in the
last column. Nuclei are counterstained with Hoechst (blue). Bars:
25 mm.
(TIF)
Figure S3 Organization of centrosomal proteins, Golgi
complex and ERES in control undifferentiated cells. (A)
Golgi complex identified by GM130 staining (top, green) and
centrosome identified by pericentrin staining (middle, red). (B)
GM130 staining (top, green) and ERES identified by Sec31
staining (middle, red). Bottom row: overlay with nuclear
counterstain (blue). Wide-field images. Bar: 10 mm.
(TIF)
Figure S4 A large range of nocodazole concentrations
and cold affect subcellular reorganization similarly.
Cells with or without cold pretreatment were differentiated in
FM with nocodazole for one day and myogenin-positive cells were
assessed for the presence of perinuclear pericentrin belts. (A) All
concentrations increased the fraction of cells with reorganized
pericentrin. Cold pre-treatment did not have an additional effect.
(B) Examples of cells with reorganized pericentrin, GM130 and
Sec31 in cultures treated with cold and 2000 ng/ml nocodazole.
Wide-field images. Bar: 10 mm.
(TIF)
Movie S1 Time-lapse recording of a C2 myoblast
expressing EB3-GFP.
(MOV)
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expressing EB3-GFP. Puncta originating at the nuclear
envelope indicate steady-state growth of new microtubules from
this area. There is also constant longitudinal movement of puncta,
originating at random cytosolic sites.
(MOV)
Movie S3 Time-lapse recording of part of a C2 myotube
expressing EB3-GFP (green) and GalT-mCherry (red), a
Golgi complex marker. The 12 o’clock sector of the middle
nucleus is particularly active in EB3 puncta movement.
(MOV)
Movie S4 Time-lapse recording of a C2 myoblast
expressing EB3-GFP, before nocodazole treatment.
(MOV)
Movie S5 Time-lapse recording of a myoblast ex-
pressing EB3-GFP from Movie S4, after nocodazole
washout.
(MOV)
Movie S6 Time-lapse recording of a C2 myotube
expressing EB3-GFP before nocodazole treatment.
(MOV)
Movie S7 Time-lapse recording of a myotube express-
ing EB3-GFP from Movie S6, after nocodazole washout.
(MOV)
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